INFEX Therapeutics
Pete Jackson is an Executive Director at INFEX Therapeutics with a strong background in life sciences leadership and entrepreneurship. Pete has founded multiple biotech companies and played a key role in the formation of the AMR Centre. Currently, Pete also serves as the Non Executive Chairman at Norwich Research Park. Jackson holds a PhD in Chemical Physics from Durham University, a Postdoc in Chemical Physics from King's College London, and BSc degrees in Physical Chemistry from University of East Anglia and University of Massachusetts Amherst.
This person is not in any teams
INFEX Therapeutics
We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.